Equity
€342,758 ▲ 6.1%
MEDSAM has made a profit without a break since 2008.
MEDSAM
Lifetime
20 annual accounts with figures on one time axis, 22 filings since 2004peak €268,904 (2022)
€183,797▼ 10.0%
lowest -€13,725 (2006)
€44,663▼ 37.1%
peak €342,758 (2025)
€342,758▲ 6.1%
€96,827▼ 32.0%
peak 1.8 FTE (2023)
-not published
Board3 names since 2021
1 director
Owners
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Result from €71,021 to €44,663Debts from €142,300 to €96,827Cash from €192,815 to €111,876
Key points
from the 2025 annual accountsTurnover
≈ €560,000 estimated
The accounts state no turnover.
Staff
2 employees on 31-12-2025
In 2025, 8 people joined and 8 left.
Liquidity
4.53 was 3.26 in 2024
Short-term debts fell from €142,300 to €96,827.
Filings
22 annual accounts since 2004
Eight of the last ten came late. The 2017 accounts came latest: 143 days after the end of the period.
Position in the sector
€342,758
More equity than 92% of companies in retail trade. Sector median €40,895 · 25,314 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as MEDSAM has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for MEDSAM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director,
- 100%equity €455,663 (2025) · 2021 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0863447478
1 manager resigning, 1 director reappointed
Resignation: (manager) · Reappointment: (director) · Permanent representative: · General meeting of 13-12-2023 · Gazette deed
Resignation: (director)
Appointment: (director) · holds 186 shares (100%) · 186 shares · General meeting of 27-05-2021 · Gazette deed
Registered office moved to Etterbeek
New registered office: 175, Rue de Haerne à 1040 ETTERBEEK · Previous registered office: 171 Rue de Haerne · General meeting of 31-05-2014 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MEDSAM Etterbeek | €439,586 | €183,797 | 78.0% | - |
| BUDIN-CONSERVA Roeselare | €419,437 | €176,491 | 30.3% | 2.6 |
| APOTHEEK VAN REETH Antwerp | €420,608 | €172,672 | 52.1% | - |
| APOTHEEK EKSTERLAAR Antwerp | €467,483 | €191,142 | 67.8% | 0.4 |
| PHARMACIE DELVIGNE DOUMONT Genappe | €451,687 | €189,736 | 41.6% | 1.7 |
| PHARMACIE PALM Sint-Gillis (bij-Brussel) | €454,539 | €168,062 | 60.1% | 1.1 |
| PHARMACIE MADOU Saint-Josse-ten-Noode | €438,219 | €224,925 | -6.4% | 2 |
These companies have the same main activity as MEDSAM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €419,000 and €467,000, founded between 2001 and 2006.
Official details
Source: KBO- Status
- Active since 16-02-2004Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.136.024.1321040 Etterbeek, since 16-02-2004
- Financial year end
- 31 December
- Peppol
- Reachable since 06-10-2025
Insights on MEDSAM
MEDSAM files the micro format. That format states no turnover. The gross margin rose from €65,770 in 2006 to €183,797 in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDSAM
- What is the company number of MEDSAM?
- The company number of MEDSAM is 0863.447.478. The VAT number is the same number with BE in front: BE 0863.447.478.
- Where is MEDSAM based?
- The registered office is at de Haernestraat 175, 1040 Etterbeek.Company details
- What does MEDSAM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of MEDSAM?
- MEDSAM is a private limited company (BV).
- When was MEDSAM founded?
- MEDSAM was founded on 16-02-2004.
- Is MEDSAM still active?
- Yes, MEDSAM is an active enterprise in the KBO register.
- How many employees does MEDSAM have?
- MEDSAM had an average of 1.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does MEDSAM fall under?
- In its 2025 annual accounts, MEDSAM states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of MEDSAM?
- The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €183,797 and 31 comparable companies (NACE 477). It probably lies between €390,000 and €1.0m. In financial year 2020 turnover was €502,201.
- Is MEDSAM profitable?
- In financial year 2025, MEDSAM made a profit of €44,663.
- Where can I find the annual accounts of MEDSAM?
- MEDSAM filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDSAM due?
- MEDSAM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.